Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial

NCT02839473 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
278
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institut Curie

Collaborators